Literature DB >> 431681

Digoxin-quinidine interaction Pharmacokinetic evaluation.

W D Hager, P Fenster, M Mayersohn, D Perrier, P Graves, F I Marcus, S Goldman.   

Abstract

Several recent reports have shown that plasma concentrations of digoxin increase when quinidine is administered along with digoxin; the present study was designed to explore the pharmacokinetics of this digoxin-quinidine interaction in six subjects. The elimination half-life of digoxin, although variable, did not change appreciably (42 vs. 44 hours) when quinidine was administered. Other pharmacokinetic values were substantially reduced in the presence of quinidine: total body clearance (from 3.08 to 1.96 ml per minute per kilogram), renal clearance (from 1.64 to 1.09 ml per minute per kilogram) and volume of distribution (from 10.87 to 7.35 liters per kilogram). The results may be explained by the displacement of digoxin from binding sites in tissue by quinidine, causing a rise in the plasma concentration of digoxin. The reduction in renal clearance of digoxin may result also from inhibition of renal secretion of digoxin by quinidine.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 431681     DOI: 10.1056/NEJM197905313002202

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  51 in total

1.  Internal medicine-epitomes of progress: digoxin, quinidine and sudden death.

Authors:  N H Holford
Journal:  West J Med       Date:  1980-09

Review 2.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

3.  Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein.

Authors:  U Mayer; E Wagenaar; J H Beijnen; J W Smit; D K Meijer; J van Asperen; P Borst; A H Schinkel
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  Itraconazole-related amaurosis and vomiting due to digoxin toxicity.

Authors:  L A Cone; R B Himelman; J N Hirschberg; J W Hutcheson
Journal:  West J Med       Date:  1996-11

Review 5.  Pharmacokinetic interactions with digoxin.

Authors:  S M Rodin; B F Johnson
Journal:  Clin Pharmacokinet       Date:  1988-10       Impact factor: 6.447

Review 6.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

7.  Clinical chemistry of anti-arrhythmic drugs.

Authors:  K G Nair
Journal:  Indian J Clin Biochem       Date:  1999-01

8.  Digoxin-quinidine interaction in patients with renal failure.

Authors:  R Hirschberg; K Schaefer; D von Herrath; G Kreutz; H Kewitz
Journal:  Klin Wochenschr       Date:  1981-05-15

9.  Effect of cimetidine on digoxin disposition in peptic ulcer patients.

Authors:  M Garty; G Perry; H Shmueli; D Ilfeld; G Boner; S Pitlik; J Rosenfeld
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Quinidine-digoxin interaction: effect of quinidine on 86Rb-uptake of human erythrocytes.

Authors:  W Doering; G G Belz
Journal:  Klin Wochenschr       Date:  1981-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.